HeartFlow Stock

Medical Technology Company

Sign up today and learn more about HeartFlow Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Wellington Management


Redwood City CA, US

Total Funding


About HeartFlow Stock

HeartFlow is a medical technology company that provides non-invasive coronary artery disease detection services. The company's main product is HeartFlow FFR Analysis, which aims to help a physician evaluate whether a patient has significant coronary artery disease. HeartFlow FFRCT Analysis uses a CT scan ordered by a physician to generate a 3D model of the patient's coronary arteries. The analysis aims to calculate the amount of blockage in the arteries and the limited blood flow. The HeartFlow FFRCT Analysis is commercially available in the United States, Canada, Europe, and Japan. 

Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 which became HeartFlow in May 2009. The company is headquartered in Redwood City, California. Notable investors include Panorama Point Partners, Capricorn Investment Group, and Baillie Gifford.


Funding History

July 2009$2.0M
August 2010$6.9M
August 2010$10.1M
December 2011$105M
January 2015$111M
November 2017$305M
March 2023$41.0M
March 2023$175M


Chief Executive Officer

John Farquhar

Chief Scientific Officer

Charles Anthony Taylor


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: